.

Pharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Formulary management
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Fomepizole - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for fomepizole?

Fomepizole is the generic ingredient in two branded drugs marketed by Mylan Institutional, Navinta Llc, Luitpold, and Par Pharm Inc, and is included in five NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Fomepizole has nine patent family members in eight countries.

There are five drug master file entries for fomepizole. Four suppliers are listed for this compound.

Summary for Generic Name: fomepizole

Tradenames:2
Patents:2
Applicants:4
NDAs:5
Drug Master File Entries: see list5
Suppliers / Packagers: see list4
Bulk Api Vendors: see list103
Patent Applications: see list947
Drug Prices:see low prices
DailyMed Link:fomepizole at DailyMed

Pharmacology for Ingredient: fomepizole

Drug ClassAntidote
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Institutional
FOMEPIZOLE
fomepizole
INJECTABLE;INJECTION078639-001Mar 3, 2008RXNoNo► Subscribe► Subscribe
Navinta Llc
FOMEPIZOLE
fomepizole
INJECTABLE;INJECTION078537-001Mar 6, 2008RXNoNo► Subscribe► Subscribe
Par Pharm Inc
ANTIZOL
fomepizole
INJECTABLE;INJECTION020696-001Dec 4, 1997RXYesYes7,553,863► SubscribeYY ► Subscribe
Luitpold
FOMEPIZOLE
fomepizole
INJECTABLE;INJECTION078368-001Dec 14, 2007RXNoNo► Subscribe► Subscribe
Mylan Institutional
FOMEPIZOLE
fomepizole
INJECTABLE;INJECTION079033-001Apr 7, 2009DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: fomepizole

Country Document Number Estimated Expiration
South Korea20080000660► Subscribe
European Patent Office1948613► Subscribe
China101163679► Subscribe
Japan5378788► Subscribe
Mexico2007013118► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc